LONDON (Alliance News) - Consort Medical PLC on Thursday noted the announcement from Belgium's UCB SA that the Cimzia Autoclicks pre-filled pen treatment for rheumatoid arthritis is available on the National Health Service in the UK.
Consort said the product has been launched on the NHS following the positive opinion from the European Medicine's Agency's Committee for Medicinal Products for Human Use.
The pen uses Consort's Bespak technology.
"We are delighted that the AutoClicks pre-filled pen autoinjector, which relies on Bespak technology at its core, has been launched in the UK market," said Jon Glenn, Consort's chief executive.
Consort shares were down 0.1% at 1,142.61 pence on Thursday morning.
By Sam Unsted; samunsted@alliancenews.com; @SamUAtAlliance
Copyright 2016 Alliance News Limited. All Rights Reserved.
